Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > IR working hard

<< Previous

Bullboard Posts

Next >>

Comment by FredTheVoiceon Mar 31, 2021 2:39pm

86 Views

Post# 32915743

RE:RE:RE:RE:RE:RE:IR working hard

A lot of what you write is OK, I understand,

BUT: since two years, all indicators where also GREEN.....no bad news, no red, ....

But two years of Sh*&T. Market wise.

But this: "I strongly beleive the SP would be at >6$ with a better timing and condition of the financing"

That is just Nostradamus......An ALIAS Nostradamus !

FTV.

<< Previous

Bullboard Posts

Next >>

Eminent acquires promising Nevada gold project